Patent Expiry
RYTM: IMCIVREE: recorded patent 11129869 expiry
July 4, 2034 · SETMELANOTIDE ACETATE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- July 4, 2034
- Company
- RHYTHM PHARMACEUTICALS, INC. (RYTM)
- Drug
- SETMELANOTIDE ACETATE
BioSniper AIPage context preserved
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
IMCIVREE: recorded patent 11129869 expiry
Orange Book application NDA213793, product 001, listed patent 11129869 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source